MEDP - Medpace Holdings, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.41B
Enterprise Value 32.34B
Trailing P/E 25.04
Forward P/E 118.07
PEG Ratio (5 yr expected) 12.03
Price/Sales (ttm)2.80
Price/Book (mrq)3.30
Enterprise Value/Revenue 32.71
Enterprise Value/EBITDA 615.54

Trading Information

Stock Price History

Beta (5Y Monthly) 1.24
52-Week Change 313.21%
S&P500 52-Week Change 3-11.36%
52 Week High 3109.09
52 Week Low 352.84
50-Day Moving Average 386.76
200-Day Moving Average 382.35

Share Statistics

Avg Vol (3 month) 3319.55k
Avg Vol (10 day) 3657.55k
Shares Outstanding 536.03M
Float 27.61M
% Held by Insiders 123.48%
% Held by Institutions 181.80%
Shares Short (Mar 12, 2020) 42.4M
Short Ratio (Mar 12, 2020) 46.52
Short % of Float (Mar 12, 2020) 410.32%
Short % of Shares Outstanding (Mar 12, 2020) 46.64%
Shares Short (prior month Feb 13, 2020) 42.28M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Dec 30, 2019

Profitability

Profit Margin 11.67%
Operating Margin (ttm)14.78%

Management Effectiveness

Return on Assets (ttm)7.54%
Return on Equity (ttm)15.26%

Income Statement

Revenue (ttm)860.97M
Revenue Per Share (ttm)24.00
Quarterly Revenue Growth (yoy)19.70%
Gross Profit (ttm)539.96M
EBITDA 150.45M
Net Income Avi to Common (ttm)100.16M
Diluted EPS (ttm)2.67
Quarterly Earnings Growth (yoy)31.00%

Balance Sheet

Total Cash (mrq)131.92M
Total Cash Per Share (mrq)3.65
Total Debt (mrq)56.19M
Total Debt/Equity (mrq)7.74
Current Ratio (mrq)0.92
Book Value Per Share (mrq)20.25

Cash Flow Statement

Operating Cash Flow (ttm)201.87M
Levered Free Cash Flow (ttm)152.36M